Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

GeneReach Biotechnology Corp. (4171) Financial Statements

GeneReach Biotechnology Corp. Financial Overview

GeneReach Biotechnology Corp.'s market cap is currently NT$896.99M. The company's EPS TTM is NT$-0.76; its P/E ratio is -40.49; and it has a dividend yield of 3.67%. GeneReach Biotechnology Corp. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 232.74MNT$ 206.49MNT$ 225.46MNT$ 750.02MNT$ 1.01B
Gross ProfitNT$ 160.93MNT$ 118.28MNT$ 27.58MNT$ 490.07MNT$ 746.98M
Operating IncomeNT$ -79.86MNT$ -131.22MNT$ -229.28MNT$ 277.85MNT$ 480.69M
EBITDANT$ -8.77MNT$ -36.31MNT$ -143.69MNT$ 343.02MNT$ 540.70M
Net IncomeNT$ -110.28MNT$ -118.73MNT$ -166.27MNT$ 221.34MNT$ 376.62M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 404.76MNT$ 503.76MNT$ 531.87MNT$ 763.97MNT$ 677.27M
Total AssetsNT$ 881.05MNT$ 1.07BNT$ 1.18BNT$ 1.62BNT$ 1.68B
Total DebtNT$ 225.22MNT$ 273.01MNT$ 257.04MNT$ 402.50MNT$ 394.61M
Net DebtNT$ 55.15MNT$ 162.74MNT$ 40.27MNT$ -346.12MNT$ -268.83M
Total LiabilitiesNT$ 284.34MNT$ 341.00MNT$ 313.71MNT$ 519.23MNT$ 596.35M
Stockholders' EquityNT$ 586.73MNT$ 716.98MNT$ 832.06MNT$ 1.07BNT$ 1.05B
Cash Flow
Free Cash FlowNT$ -20.22MNT$ -31.69MNT$ -60.59MNT$ 307.17MNT$ 333.20M
Operating Cash FlowNT$ -13.86MNT$ -23.22MNT$ -38.67MNT$ 357.63MNT$ 348.99M
Investing Cash FlowNT$ 127.00MNT$ -70.21MNT$ -249.91MNT$ -48.01MNT$ -41.70M
Financing Cash FlowNT$ -63.17MNT$ 3.43MNT$ -215.88MNT$ -228.28MNT$ 43.48M

Currency in TWD

GeneReach Biotechnology Corp. Earnings and Revenue History

-600M0600M1.2B-100 %-50 %0 %50 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

GeneReach Biotechnology Corp. Liabilities to Assets

0600M1.2B1.8B16 %24 %32 %40 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

GeneReach Biotechnology Corp. Cash Flow

-400M-200M0200M400M2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

GeneReach Biotechnology Corp. Forecast EPS vs Actual EPS

-0.8-0.6-0.4-0.200.2Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >